Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Baricitinib 2 MG [Olumiant]
DRUG
2 trials
Sponsors
Washington University School of Medicine
, Peking University People's Hospital
Conditions
Cicatrizing Conjunctivitis
Immune Thrombocytopenia
Mucous Membrane Pemphigoid
Phase 2
Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
Terminated
NCT05263505
Washington University School of Medicine
Cicatrizing Conjunctivitis, Mucous Membrane Pemphigoid
Start: 2022-02-21
End: 2023-09-11
Updated: 2023-11-07
Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
NCT05852847
Peking University People's Hospital
Immune Thrombocytopenia
Start: 2023-05-16
End: 2025-05-31
Target: 216
Updated: 2023-06-13